Similarities between Chemotherapy and Plasma cell dyscrasia
Chemotherapy and Plasma cell dyscrasia have 25 things in common (in Unionpedia): AL amyloidosis, Anemia, Antibody, Apoptosis, Autonomic nervous system, Bone marrow, Bortezomib, Central nervous system, Complete blood count, Gastrointestinal tract, Heart arrhythmia, Lymphoma, Malignancy, Multiple myeloma, Mutation, Neoplasm, Non-Hodgkin lymphoma, Oncogene, Peripheral neuropathy, Proteasome inhibitor, Rheumatoid arthritis, Rituximab, Stem cell, Thrombocytopenia, Vasculitis.
AL amyloidosis
Amyloid light-chain (AL) amyloidosis, primary systemic amyloidosis (PSA) or just primary amyloidosis is the most common form of systemic amyloidosis in the US.
AL amyloidosis and Chemotherapy · AL amyloidosis and Plasma cell dyscrasia ·
Anemia
Anemia is a decrease in the total amount of red blood cells (RBCs) or hemoglobin in the blood, or a lowered ability of the blood to carry oxygen.
Anemia and Chemotherapy · Anemia and Plasma cell dyscrasia ·
Antibody
An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune system to neutralize pathogens such as pathogenic bacteria and viruses.
Antibody and Chemotherapy · Antibody and Plasma cell dyscrasia ·
Apoptosis
Apoptosis (from Ancient Greek ἀπόπτωσις "falling off") is a process of programmed cell death that occurs in multicellular organisms.
Apoptosis and Chemotherapy · Apoptosis and Plasma cell dyscrasia ·
Autonomic nervous system
The autonomic nervous system (ANS), formerly the vegetative nervous system, is a division of the peripheral nervous system that supplies smooth muscle and glands, and thus influences the function of internal organs.
Autonomic nervous system and Chemotherapy · Autonomic nervous system and Plasma cell dyscrasia ·
Bone marrow
Bone marrow is a semi-solid tissue which may be found within the spongy or cancellous portions of bones.
Bone marrow and Chemotherapy · Bone marrow and Plasma cell dyscrasia ·
Bortezomib
Bortezomib (BAN, INN and USAN; marketed as Velcade by Takeda Oncology; Chemobort by Cytogen and Bortecad by Cadila Healthcare) is an anti-cancer drug and the first therapeutic proteasome inhibitor to be used in humans.
Bortezomib and Chemotherapy · Bortezomib and Plasma cell dyscrasia ·
Central nervous system
The central nervous system (CNS) is the part of the nervous system consisting of the brain and spinal cord.
Central nervous system and Chemotherapy · Central nervous system and Plasma cell dyscrasia ·
Complete blood count
A complete blood count (CBC), also known as a complete blood cell count, full blood count (FBC), or full blood exam (FBE), is a blood panel requested by a doctor or other medical professional that gives information about the cells in a patient's blood, such as the cell count for each cell type and the concentrations of various proteins and minerals.
Chemotherapy and Complete blood count · Complete blood count and Plasma cell dyscrasia ·
Gastrointestinal tract
The gastrointestinal tract (digestive tract, digestional tract, GI tract, GIT, gut, or alimentary canal) is an organ system within humans and other animals which takes in food, digests it to extract and absorb energy and nutrients, and expels the remaining waste as feces.
Chemotherapy and Gastrointestinal tract · Gastrointestinal tract and Plasma cell dyscrasia ·
Heart arrhythmia
Heart arrhythmia (also known as arrhythmia, dysrhythmia, or irregular heartbeat) is a group of conditions in which the heartbeat is irregular, too fast, or too slow.
Chemotherapy and Heart arrhythmia · Heart arrhythmia and Plasma cell dyscrasia ·
Lymphoma
Lymphoma is a group of blood cancers that develop from lymphocytes (a type of white blood cell).
Chemotherapy and Lymphoma · Lymphoma and Plasma cell dyscrasia ·
Malignancy
Malignancy is the tendency of a medical condition to become progressively worse.
Chemotherapy and Malignancy · Malignancy and Plasma cell dyscrasia ·
Multiple myeloma
Multiple myeloma, also known as plasma cell myeloma, is a cancer of plasma cells, a type of white blood cell normally responsible for producing antibodies.
Chemotherapy and Multiple myeloma · Multiple myeloma and Plasma cell dyscrasia ·
Mutation
In biology, a mutation is the permanent alteration of the nucleotide sequence of the genome of an organism, virus, or extrachromosomal DNA or other genetic elements.
Chemotherapy and Mutation · Mutation and Plasma cell dyscrasia ·
Neoplasm
Neoplasia is a type of abnormal and excessive growth of tissue.
Chemotherapy and Neoplasm · Neoplasm and Plasma cell dyscrasia ·
Non-Hodgkin lymphoma
Non-Hodgkin lymphoma (NHL) is a group of blood cancers that includes all types of lymphoma except Hodgkin's lymphomas.
Chemotherapy and Non-Hodgkin lymphoma · Non-Hodgkin lymphoma and Plasma cell dyscrasia ·
Oncogene
An oncogene is a gene that has the potential to cause cancer.
Chemotherapy and Oncogene · Oncogene and Plasma cell dyscrasia ·
Peripheral neuropathy
Peripheral neuropathy (PN) is damage to or disease affecting nerves, which may impair sensation, movement, gland or organ function, or other aspects of health, depending on the type of nerve affected.
Chemotherapy and Peripheral neuropathy · Peripheral neuropathy and Plasma cell dyscrasia ·
Proteasome inhibitor
Proteasome inhibitors are drugs that block the action of proteasomes, cellular complexes that break down proteins.
Chemotherapy and Proteasome inhibitor · Plasma cell dyscrasia and Proteasome inhibitor ·
Rheumatoid arthritis
Rheumatoid arthritis (RA) is a long-term autoimmune disorder that primarily affects joints.
Chemotherapy and Rheumatoid arthritis · Plasma cell dyscrasia and Rheumatoid arthritis ·
Rituximab
Rituximab, sold under the brand name Rituxan among others, is a medication used to treat certain autoimmune diseases and types of cancer.
Chemotherapy and Rituximab · Plasma cell dyscrasia and Rituximab ·
Stem cell
Stem cells are biological cells that can differentiate into other types of cells and can divide to produce more of the same type of stem cells.
Chemotherapy and Stem cell · Plasma cell dyscrasia and Stem cell ·
Thrombocytopenia
Thrombocytopenia is a condition characterized by abnormally low levels of thrombocytes, also known as platelets, in the blood.
Chemotherapy and Thrombocytopenia · Plasma cell dyscrasia and Thrombocytopenia ·
Vasculitis
Vasculitis is a group of disorders that destroy blood vessels by inflammation.
Chemotherapy and Vasculitis · Plasma cell dyscrasia and Vasculitis ·
The list above answers the following questions
- What Chemotherapy and Plasma cell dyscrasia have in common
- What are the similarities between Chemotherapy and Plasma cell dyscrasia
Chemotherapy and Plasma cell dyscrasia Comparison
Chemotherapy has 419 relations, while Plasma cell dyscrasia has 180. As they have in common 25, the Jaccard index is 4.17% = 25 / (419 + 180).
References
This article shows the relationship between Chemotherapy and Plasma cell dyscrasia. To access each article from which the information was extracted, please visit: